抗血栓剤の手術前管理における地域薬剤師の役割:障壁,促進要因,将来の方向性に関する定性的な研究
Andreas Capiau1,2, Isaura Kint3, Els Mehuys3
1Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000, Ghent, Belgium. Andreas.Capiau@UGent.be.
International journal of clinical pharmacy
|August 30, 2025
まとめ
コミュニティの薬剤師 (CP) は,外科手術後の抗血栓管理に限られた役割を果たし,しばしば手術後に反応的に行動します. 彼らの関与を強化するには,知識のギャップを埋め,ガイドラインの透明性を向上させ,処方者とのコミュニケーションを容易にする必要があります.
科学分野:
- 薬理学について
- 患者の安全
- 医療の提供
背景:
- 抗血栓剤は高リスクの薬であり,特に手術前には出血のリスクがあります.
- 侵襲的処置では出血と血栓のリスクをバランスとすることが重要です.
- 術後の抗血栓管理における地域薬剤師 (CP) の役割はよく定義されていません.
研究 の 目的:
- 術後の抗血栓管理におけるCPの経験を調査する.
- この分野におけるCPの関与を拡大するための障壁と促進要因を特定する.
主な方法:
- ベルギーの13人の医療従事者との半構造面接による定性研究.
- 理論的領域の枠組みによるインタビュー
- オープン・アクシアル・コーディングを用いたインタビューのテーマ分析
主要な成果:
- 現在,CPの関与は限られており,主として解約後のものです.
- 障壁には知識の空白,時間的制約,不明瞭なガイドライン,処方医へのアクセス不足などがあります.
- ファシリテーターには 患者との関係や 薬の管理や 本質的な動機付けが含まれます
- CPsは,構造化されたトレーニングとより良いコミュニケーションチャネルで,より積極的な役割を望んでいます.
結論:
- 術後の抗血栓管理におけるCPの役割は,現在,特に術前では制限されています.
- 特定された障壁を取り除き改善策を導入することで,CPの貢献度が向上する.
- 発見を検証し,介入を導くためにさらなる研究が必要である.
関連する概念動画
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Peripheral Artery Disease V: Postoperative Nursing Management
24
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
24
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
644
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
644
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Venous Thrombosis IV: Nursing Management
22
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
22
Anticoagulant Drugs: Low-Molecular-Weight Heparins
889
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
889


